-
公开(公告)号:EP4452306A1
公开(公告)日:2024-10-30
申请号:EP22844129.1
申请日:2022-12-23
申请人: Bavarian Nordic A/S
-
公开(公告)号:EP4452305A1
公开(公告)日:2024-10-30
申请号:EP22844103.6
申请日:2022-12-22
申请人: Bavarian Nordic A/S
发明人: HINTERBERGER, Maria , MEDINA ECHEVERZ, José , HABJAN, Matthias , HAUSMANN, Jürgen , KALLA, Markus , BERRAONDO LÓPEZ, Pedro
IPC分类号: A61K39/00 , A61K39/395 , A61P35/00 , C07K14/82 , C12N15/86 , C07K14/705
-
53.
公开(公告)号:EP4061406A1
公开(公告)日:2022-09-28
申请号:EP20820341.4
申请日:2020-11-20
申请人: Bavarian Nordic A/S
发明人: LAUTERBACH, Henning , HINTERBERGER, Maria , MEDINA ECHEVERZ, Jose , HABJAN, Matthias , HAUSMANN, Jürgen , KALLA, Markus
IPC分类号: A61K39/00 , C07K14/705 , A61P35/00 , C12N15/86 , C07K14/82
-
公开(公告)号:EP3778904A1
公开(公告)日:2021-02-17
申请号:EP20172647.8
申请日:2013-10-28
申请人: Bavarian Nordic A/S
发明人: Steigerwald, Robin , Brinkmann, Kay
IPC分类号: C12N15/863 , A61K39/00 , A61P37/04 , A61P43/00
摘要: The invention encompasses recombinant poxviruses, preferably modified Vaccinia Ankara (MVA) viruses, comprising a Pr13.5 promoter operably linked to a nucleotide sequence encoding an antigen and uses thereof. The invention is drawn to compositions and methods for the induction of strong CD8 T cell and antibody responses to a specific antigen(s) by administering one or more immunizations of the recombinant MVA to a mammal, preferably a human.
-
55.
公开(公告)号:EP3727446A1
公开(公告)日:2020-10-28
申请号:EP18839618.8
申请日:2018-12-18
-
公开(公告)号:EP3065770B1
公开(公告)日:2020-10-28
申请号:EP14803277.4
申请日:2014-10-31
申请人: Bavarian Nordic A/S
发明人: ROUNTREE, Ryan , FOY, Susan , MANDL, Stefanie , DELCAYRE, Alain
-
公开(公告)号:EP2912183B1
公开(公告)日:2020-05-06
申请号:EP13783852.0
申请日:2013-10-28
申请人: Bavarian Nordic A/S
发明人: STEIGERWALD, Robin , BRINKMANN, Kay
IPC分类号: C12N15/863 , A61K39/00
-
公开(公告)号:EP3639851A1
公开(公告)日:2020-04-22
申请号:EP19164313.9
申请日:2013-03-15
申请人: Bavarian Nordic A/S
摘要: Provided herein are immunogenic compositions comprising a recombinant modified vaccinia virus Ankara (MVA) comprising a nucleic acid sequence encoding a CD40 ligand (CD40L) and a nucleic acid sequence encoding a heterologous disease-associated antigen, wherein the immunogenic composition induces increases T-cell immune responses specific for the heterologous disease-associated antigen when administered to a human host, and related methods and uses.
-
公开(公告)号:EP3638302A1
公开(公告)日:2020-04-22
申请号:EP18749863.9
申请日:2018-06-14
-
公开(公告)号:EP3624845A1
公开(公告)日:2020-03-25
申请号:EP18728753.7
申请日:2018-05-15
IPC分类号: A61K39/275 , A61K47/20 , A61K39/00
-
-
-
-
-
-
-
-
-